MTOR and cancer: Moreover, celastrol treatment ameliorated cisplatin-induced nephrotoxicity by suppressing NF-κB in mice [146] and also had effects in cancer models by activating ROS/JNK signaling and blocking Akt/mammalian target of rapamycin (m-TOR) signaling pathway [147].